Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:17 Issue:1 Number:5 ISSN#:2564-2537
Author Verified
RCT
ACE Report #13291
Ace Report Cover Tumour

Local Lidocaine Plus Ketorolac Superior to Lidocaine Alone for Pain Relief After Core Needle Biopsy


How to Cite

OrthoEvidence. Local Lidocaine Plus Ketorolac Superior to Lidocaine Alone for Pain Relief After Core Needle Biopsy. ACE Report. 2021;17(1):5. Available from: https://myorthoevidence.com/AceReport/Report/13291

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Ketorolac plus Lidocaine vs Lidocaine for pain relief following core needle soft tissue biopsy: A CONSORT-compliant double-blind randomized controlled study

Medicine (Baltimore). 2021 Feb 19;100(7): e24721.

Contributing Authors: T Chobpenthai T Ingviya P Thanindratarn R Jaiwithee K Sutthivaiyakit

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and twenty-eight patients with musculoskeletal tumours and scheduled for a core needle biopsy were randomized to receive a pre-biopsy injection of 10 mL 2% lidocaine plus adrenaline (n=64) or 10 mL 2% lidocaine plus adrenaline plus 30 mg of ketorolac (n=64) for the relief of post-procedural pain. The outcome of interest was pain severity after injection evaluated on a Visual Analogue S...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.